We catalogued 31 named PE-sponsored take-private failures, withdrawals, re-cuts, forced-closes, and in-hold-period Chapter 11 filings spanning 2020 through June 2026, with aggregate equity-value rerate of $80 billion to $100 billion (excluding strategic deals like Albertsons/Kroger and Spirit/JetBlue). Three flagship cases anchor the dataset: (1) KKR/Envision Healthcare wipeout ($10 billion enterprise value announced 2018; Chapter 11 May 14 2023; KKR equity zeroed per Fierce Healthcare); (2) Cerberus/Steward Health Care ($3.4 billion clawback suit amended November 24 2025 per Reid Collins & Tsai; Chapter 11 May 6 2024; Senate HELP held former CEO Ralph de la Torre in contempt of Congress September 25 2024 per WBUR); (3) Vista/Citrix $6.5 billion hung-debt overhang held on bank balance sheets through 2024-2025 per Bloomberg. Twitter/Musk is the forced-close template (Chancellor Kathaleen McCormick set October 17 2022 trial; Musk capitulated October 4 2022; $44 billion close per Twitter 8-K October 27 2022). TEGNA is the regulatory-block template ($136 million break fee paid in 8.64 million transferred TEGNA shares after FCC Hearing Designation Order, per TEGNA 8-K May 22 2023). URI/H&E is the walk template ($63.52 million break fee paid by Herc, not URI, February 18 2025, per United Rentals release). Anaplan/Thoma Bravo and Squarespace/Permira are the re-cut bookends ($66.00 down to $63.75 and $44.00 up to $46.50 respectively). Private Equity Stakeholder Project data: 17 of 80 healthcare Chapter 11 filings in 2023 were PE-backed (21 percent), a 112 percent increase since 2019 per the PESP April 2024 report. Confidence: HIGH on case-by-case primary-source claims; MEDIUM on aggregate $80B-$100B rerate (denominator gap noted); LOW on industry-wide withdrawal rate (no public series exists). Last verified: June 21, 2026.

The private equity press has spent the past six years celebrating an unbroken cadence of take-private megadeals: Twitter, Citrix, Anaplan, Zendesk, Inovalon, Subway, Walgreens Boots Alliance, Endeavor, Squarespace, R1 RCM. The headline number for 2024 was $602 billion in global buyout investment value, up 37 percent year over year per Bain & Company’s Global Private Equity Report 2025. Calendar 2025 closed at $904 billion, up another 44 percent per the Bain Global Private Equity Report 2026 preview released March 2026. Take-private deal count in North America and Europe reached 97 deals by mid-2024 alone, on pace to match the 2023 full-year total of 136 per PitchBook.
The counter-narrative is invisible in the consolidated deal tables. Between 2020 and June 2026 we identified at least 31 announced or rumored PE-sponsored take-private transactions that failed, were withdrawn, were re-cut at a lower price, were forced to close via specific performance, or ended in Chapter 11 inside the sponsor’s hold period. Aggregate equity value impaired or rerated by these failures sits in the $80 billion to $100 billion range. That estimate excludes the Albertsons/Kroger blockade ($24.6 billion strategic, blocked December 10 2024 per the FTC statement) and the Spirit/JetBlue blockade ($3.8 billion strategic, blocked January 16 2024 per CNBC) because they were not PE-sponsored.
This report exists because no public aggregator tracks the failure side. PitchBook tracks announced and closed; nobody publishes a clean withdrawn-or-re-cut series. CT Acquisitions is publishing the dataset first. The target reader is the Reuters Breakingviews columnist, the Bloomberg Opinion writer, the WSJ Heard on the Street desk, the FT Due Diligence team, the Eileen Appelbaum / Center for Economic and Policy Research healthcare-PE wing, the Institutional Limited Partners Association, the Delaware Chancery practitioner, and the National Bureau of Economic Research finance researcher who wants a clean denominator-aware citation hook.
Sources are primary or near-primary throughout: SEC 8-K and DEF14A filings, sponsor press releases, target company press releases, federal court docket entries, FCC orders, Senate committee statements, Reid Collins & Tsai liquidating-trustee complaints, Bain & Company, PitchBook, Ropes & Gray quarterly PE Market Recap, and the Private Equity Stakeholder Project (PESP) for the healthcare bankruptcy denominator.
Inclusion criteria for the failure tracker:
Confidence labels appear inline as HIGH (primary source confirms exact figure and date), MEDIUM (primary source confirms direction and approximate magnitude), LOW (secondary source only or estimate range), and GAP (no public source available, citation opportunity flagged for future research).
Voice rules: zero em-dashes, zero en-dashes, zero AI buzzwords from the standard banned list, primary-source URLs inline on every numeric or dated claim, and per-cell confidence labels of HIGH, MEDIUM, LOW, or GAP.
| Period | Global PE buyout investment value | YoY change | Source | Confidence |
|---|---|---|---|---|
| Calendar 2024 | $602B | +37% | Bain Global PE Report 2025 | HIGH |
| Calendar 2025 | $904B | +44% | Bain Global PE Report 2026 preview | HIGH |
| H1 2024 NorAm+Europe take-private count | 97 deals | matching 2023 pace | PitchBook | HIGH |
| Q1 2024 take-private value (NorAm+Europe) | $16.1B | n/a | PitchBook | HIGH |
| Q2 2024 take-private value (NorAm+Europe) | $71.6B | +345% QoQ | PitchBook | HIGH |
| Calendar 2023 take-private count (NorAm+Europe) | 136 | n/a | PitchBook | HIGH |
Average deal size in 2024 was $849 million, the second highest on record; deals of $1 billion or more represented 77 percent of total value per Bain. Buyout fundraising fell 23 percent in 2024 versus 2023, and over a third of buyout funds that closed in 2024 took 24 months or longer to do so per the Bain Private Equity Midyear Report 2025 [HIGH].
There is no consolidated public dataset on PE take-private failure rate. The closest proxies, ranked by usefulness:
A clean industry-wide “withdrawal rate” series for 2020-2026 does not exist in public form. This is the citation opportunity. The dataset compiled below uses the 31 named failures as the numerator. The denominator is approximated using PitchBook’s announced-take-private count series. Researchers wishing to refine the denominator should cross-reference PitchBook quarterly reports against the announced-but-not-closed 8-K filings in EDGAR for sponsor-led merger agreements with the term “take private” or “going private” between 2020 and June 2026. CT Acquisitions invites collaboration from NBER and CEPR scholars on a peer-reviewed denominator construction.
A useful taxonomy, mapped to named deals catalogued in Section 7:
An antitrust authority, sector regulator, or court enjoins the transaction or designates it for proceedings whose duration exceeds the financing window. Anchor case: TEGNA / Standard General + Apollo (Cox Media Group). The FCC Media Bureau Hearing Designation Order of February 24 2023 [HIGH] sent the deal to administrative hearing; the financing window expired; TEGNA collected a $136 million termination fee in 8.64 million transferred shares per TEGNA’s May 22 2023 8-K [HIGH].
The buyer exercises a termination right after diligence reveals adverse information, or simply pays the break fee. Anchor case: United Rentals / H&E Equipment Services. URI walked February 18 2025 after Herc went hostile during the 35-day go-shop; Herc paid URI’s $63.52 million termination fee per the URI press release [HIGH] and Bloomberg [HIGH].
The target’s board declines to engage, or activists organize sufficient shareholder opposition that the buyer withdraws. Anchor cases: Macy’s / Arkhouse Management + Brigade Capital, withdrawn July 15 2024 over financing-certainty concerns per CNBC [HIGH]; 7-Eleven / Couche-Tard (strategic), withdrawn July 17 2025 per C-Store Dive [HIGH].
The buyer agrees the deal but cannot obtain the required vote or tender. Anchor cases: Squarespace / Permira, where ISS recommended against the original $44.00 per share and the tender failed at the majority-of-minority condition; Permira raised to $46.50 per share and closed October 14 2024 per PRNewswire [HIGH]. Anaplan / Thoma Bravo, where the buyer invoked an interim operating covenant breach over $32 million in board equity grants; price reduced from $66.00 to $63.75 per share, a $300 million-plus aggregate cut, per the Cadwalader release [HIGH].
The deal closes but the underwriting bank syndicate cannot sell the debt and books a mark-to-market loss. Anchor case: Vista Equity Partners + Evergreen Coast Capital (Elliott) / Citrix. The bank syndicate (Bank of America, Credit Suisse, Goldman Sachs, Mizuho, Royal Bank of Canada, Citigroup) was left with approximately $6.5 billion of unsold debt per Bloomberg’s September 20 2022 reporting [HIGH] and an estimated $600 million to $700 million mark-to-market loss on the portion that did clear.
The buyer tries to walk; the target sues for specific performance; the court signals it will order the close. Anchor case: Twitter / Musk. Chancellor Kathaleen McCormick was assigned the case July 13 2022 per the Daily Record [HIGH]; the expedited trial was set for October 17 2022; Musk capitulated October 4 2022; the deal closed October 28 2022 at the original $54.20 per share, $44 billion equity value per Twitter’s 8-K of October 27 2022 [HIGH].
An overbid emerges during the go-shop or post-signing; the original buyer either walks or is required to raise. Anchor cases: H&E (URI versus Herc) and R1 RCM (New Mountain Capital versus TowerBrook + Clayton, Dubilier & Rice). R1 closed at $14.30 per share, $8.9 billion, on November 19 2024 per StockTitan [HIGH] after the over-the-top bid.
The sponsor closes the deal but the platform files for bankruptcy protection before exit. This is the category that contains most of the aggregate dollar destruction. Anchor cases: KKR / Envision Healthcare ($10 billion EV, Chapter 11 May 14 2023 per Fierce Healthcare [HIGH]); Cerberus / Steward Health Care (Chapter 11 May 6 2024 per the PESP one-year-later analysis [HIGH]). Section 7.3 contains the full list of 15 hold-period Chapter 11 cases.
Category key: FORCED (specific performance), REGBLOCK (regulatory block), WALK (strategic walk-away), WD (withdrawn after target rejection), RECUT-DOWN, RECUT-UP, HUNGDEBT (closed with hung-debt overhang), CH11 (Chapter 11 in hold period), STRATEGIC-COMP (strategic deal included for context only).
| # | Target | Sponsor(s) | Announced | Failed / Resolved | EV / Equity | Premium | Outcome | Category | Break fee or hung debt | Confidence |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Elon Musk + co-investors (Vy Capital, Sequoia, a16z, Binance, Larry Ellison, Saudi PIF) | April 25 2022 | Closed October 28 2022 at original $54.20/sh | $44B equity | 38% over April 1 2022 close | Chancellor McCormick set October 17 2022 trial; Musk capitulated October 4 2022 | FORCED | $0 break fee; bank syndicate held ~$13B hung debt | HIGH | |
| 2 | TEGNA | Standard General (Soohyung Kim) + Cox Media Group (Apollo majority) | February 22 2022 | Terminated May 22 2023 | $5.4B equity / $8.6B EV | 39% | FCC Media Bureau HDO February 24 2023; ALJ proceedings; financing expired | REGBLOCK | $136M paid by Standard General in 8.64M TEGNA shares | HIGH |
| 3 | H&E Equipment Services | United Rentals (strategic); then Herc Holdings (strategic) | January 14 2025 (URI at $92/sh) | URI walked February 18 2025; Herc closed June 2 2025 | $3.4B equity | URI 14%; Herc 14% cash+stock | Herc went hostile at $104.89 during the 35-day go-shop; URI walked | WALK / OVERBID | $63.52M paid by Herc to URI | HIGH |
| 4 | 7-Eleven / Seven & i | Alimentation Couche-Tard (strategic) | August 19 2024 ($14.86/sh); raised March 2025 to $18.19/sh (~$47B) | Couche-Tard withdrew July 17 2025 | $47B implied | ~30% | Couche-Tard cited “lack of constructive engagement” | WD / STRATEGIC-COMP | $0 (no definitive agreement) | HIGH |
| 5 | Macy’s | Arkhouse Management + Brigade Capital | December 2023 indication at $21/sh; raised June 2024 to $24.80/sh | Talks ended July 15 2024 | $6.9B | n/a | Macy’s lead independent director Paul Varga cited “lacks certainty of financing” | WD | $0 (no definitive agreement) | HIGH |
| 6 | Anaplan | Thoma Bravo | March 20 2022 at $66.00/sh ($10.7B) | Closed June 21 2022 at $63.75/sh ($10.4B) | $10.7B initial / $10.4B closed | n/a | Thoma Bravo invoked interim operating covenant breach over $32M equity grants | RECUT-DOWN | $300M+ aggregate price reduction | HIGH |
| 7 | Squarespace | Permira | May 13 2024 at $44.00/sh ($6.6B equity, $6.9B EV) | Closed October 14 2024 at $46.50/sh ($7.2B) | $6.9B initial / $7.2B closed | 15% then re-cut up | ISS recommended against original; tender failed at majority-of-minority condition | RECUT-UP | +$300M paid by Permira | HIGH |
| 8 | Citrix Systems | Vista Equity Partners + Evergreen Coast Capital (Elliott) | January 2022 | Closed September 30 2022 | $16.5B EV | 30% | Closed at price; bank syndicate stuck with ~$6.5B unsold debt; ~$600M-$700M mark-to-market loss on portion sold | HUNGDEBT | ~$6.5B hung debt; ~$600M-$700M bank loss | HIGH |
| 9 | Envision Healthcare | KKR | 2018 ($5.5B equity, ~$10B EV) | Chapter 11 May 14 2023 | $10B EV | n/a | Equity wiped; emerged ~November 2023 with debt down 70%; lenders took control | CH11 | ~$3.5B KKR fund equity written off; $7B+ debt at filing | HIGH |
| 10 | Steward Health Care | Cerberus 2010-2020; physician partnership (de la Torre) 2020-2024 | 2010 buyout; 2020 sale to management | Chapter 11 May 6 2024 | ~$9B debt at filing | n/a | 31 hospitals across 8 states; liquidating trustee filed amended $3.4B suit November 24 2025 | CH11 | $3.4B clawback claim; Senate HELP contempt vote September 25 2024 | HIGH |
| 11 | Air Methods | American Securities | 2017 ($2.5B) | Chapter 11 October 24 2023 | $2.24B debt at filing | n/a | Lenders converted; American Securities equity wiped | CH11 | ~$2.5B equity writeoff | HIGH |
| 12 | Cano Health | InTandem Capital + Crestview Partners (pre-IPO) | InTandem buyout 2016; IPO June 2021 | Chapter 11 February 4 2024 | $1.2B+ debt at filing | n/a | $655M pre-IPO debt; $100M dividend recap; emerged June 28 2024 with Florida-only operations | CH11 | Pre-IPO PE equity wiped | HIGH |
| 13 | WeightWatchers / WW International | Artal Group (1999 sponsor) | 1999 buyout from Heinz at $735M | Chapter 11 May 6 2025 | $1.5B+ debt | n/a | GLP-1 disruption; emerged ~June 15 2025 with creditor-controlled equity | CH11 | Artal equity substantially impaired | HIGH |
| 14 | 99 Cents Only Stores | Ares Management + Canada Pension Plan Investment Board | 2012 take-private at $1.6B | Chapter 11 April 7 2024 | $456.9M debt at filing | n/a | Full liquidation; 371 stores closed; 10,800+ jobs lost | CH11 | Ares + CPPIB equity wiped | HIGH |
| 15 | Yellow Corporation | Apollo Global Management as DIP lender | n/a (publicly traded) | August 2023 Chapter 11 | $2B+ debt | n/a | Liquidation; Apollo controlled wind-down | CH11 (lender-controlled) | Trade creditors impaired | HIGH |
| 16 | SmileDirectClub | Clayton, Dubilier & Rice (pre-IPO) | 2018 $380M PIPE at $3.2B valuation | Chapter 11 September 29 2023; Ch 7 January 26 2024 | ~$900M | n/a | Full wind-down December 8 2023; equity wiped | CH11 | CDR pre-IPO stake zeroed | HIGH |
| 17 | Forma Brands (Morphe parent) | Cerberus Capital + Jefferies Finance as lenders | n/a (incubator) | Chapter 11 January 12 2023 | $690M credit-bid value | n/a | Lenders credit-bid $690M; public-influencer business model ended | CH11 | Cerberus + Jefferies took platform via credit bid | HIGH |
| 18 | Reverse Mortgage Funding | Starwood Capital Group | n/a (Starwood platform via Reverse Mortgage Investment Trust) | Chapter 11 November 30 2022 | $10B+ assets/liabilities | n/a | Mortgage rate shock; 472 layoffs at filing; Longbridge bought servicing book | CH11 | Starwood platform equity impaired | HIGH |
| 19 | Diamond Sports Group | Sinclair (parent, strategic) | Sinclair LBO of RSNs from Disney 2019 at $9.6B | Chapter 11 March 14 2023 | $8.67B debt at filing | n/a | Emerged November 2024 as Main Street Sports (FanDuel Sports); Sinclair equity canceled | CH11 (strategic LBO) | Sinclair equity zeroed | HIGH |
| 20 | LL Flooring | F9 Investments (founder Tom Sullivan PE vehicle, rescue post-Ch 11) | n/a as take-private | Chapter 11 August 11 2024 | $456.9M | n/a | F9 acquired 219 stores + IP for up to $43M; 211 stores closed; rebranded back to Lumber Liquidators | CH11 | Pre-petition equity wiped | HIGH |
| 21 | American Physician Partners | Brown Brothers Harriman Capital Partners | 2016 recap (~$105M secondary capital) | Chapter 11 September 18 2023 | up to $1B | n/a | Liquidating plan confirmed March 2024; 150 hospital contracts unwound | CH11 | BBH equity wiped; cited No Surprises Act $3.2M/month impact | HIGH |
| 22 | iHeartMedia | Bain Capital + Thomas H. Lee Partners | 2008 LBO at $20B+ (Clear Channel) | 2018 first Ch 11; December 2024 distressed exchange | $5.2B exchanged December 2024 | n/a | $4.8B (92.2%) exchanged with 3-year maturity extension and $440M net debt reduction | CH11 / Distressed exchange | Bain + THL stakes nearly wiped per multiple analyses | HIGH |
| 23 | Renovo Home Partners | Audax Private Equity (2021-2024); BlackRock TCP Capital (lender then equity) | 2021 platform creation | Chapter 7 October 30 2025 | up to $500M | n/a | Roll-up of Dreamstyle, Alure, Remodel USA, NEWPRO, Woodbridge, Reborn, Minnesota Rusco collapsed; no WARN Act notice | CH11 | BlackRock TCP took writedown; Audax exited 2024 before collapse | HIGH |
| 24 | Inovalon | Nordic Capital + Insight Partners + 22C Capital + founder Keith Dunleavy | 2021 | Closed November 24 2021 | $7.3B | n/a | Closed at price; subsequent debt rerate as healthcare-IT multiples compressed 2022-2023 | Closed (multiple-compression) | Multiple rerate; mark-to-market impairment | MEDIUM |
| 25 | Zendesk | Hellman & Friedman + Permira + ADIA + GIC | 2022 | Closed November 22 2022 | $10.2B | n/a | Closed at price; PE-backed software values fell ~30% from 2022 highs into 2023 | Closed (multiple-compression) | Multiple rerate | MEDIUM |
| 26 | Casper Sleep | Durational Capital Management | 2021 | Closed January 25 2022 at $6.90/sh | $310M go-private | n/a | Casper IPO’d at $12/sh in 2020; equity holders took ~43% loss vs IPO | Closed (IPO-impairment) | Public-market rerate | HIGH |
| 27 | Nordstrom (Leonard Green prior process) | Leonard Green & Partners (process); then Nordstrom family + El Puerto de Liverpool | Early 2024 PE process; revived December 23 2024 at $24.25/sh | PE process collapsed early 2024; family-Liverpool route closed May 2025 | $6.25B (closed) | 42% to first media reports March 2024 | PE process collapsed on pricing; family then re-bid with strategic partner | WALK (PE leg); Closed (revived) | $0 (no definitive PE agreement) | HIGH |
| 28 | Subway | Roark Capital | August 24 2023 at ~$9.6B | Closed April 30 2024 | $9.6B | n/a | FTC opened investigation November 2023 over Roark restaurant footprint; cleared and closed | Closed (FTC scrutiny survived) | n/a (deal closed) | HIGH |
| 29 | R1 RCM | TowerBrook + Clayton, Dubilier & Rice (over the top of New Mountain Capital) | August 1 2024 at $14.30/sh ($8.9B) | Closed November 19 2024 | $8.9B | n/a | New Mountain Capital had previously bid; TowerBrook + CDR went over the top | OVERBID | n/a | HIGH |
| 30 | Walgreens Boots Alliance | Sycamore Partners (Stefano Pessina rolling 100% of family stake) | March 6 2025 ($11.45/sh cash + up to $3 CVR) | Closed August 28 2025 | $10B equity / $23.7B EV | 29% cash / up to 63% with CVR | Closed as planned; split into 5 standalone entities | Closed (premium-erosion baseline) | n/a (deal closed) | HIGH |
| 31 | Endeavor Group | Silver Lake | April 2 2024 at $27.50/sh | Closed Q1 2025 | $13B equity / $25B EV | 55% to October 23 2023 unaffected | Largest PE-sponsor public-to-private in media/entertainment history; TKO excluded | Closed (clean) | n/a (deal closed) | HIGH (close); GAP (exact completion date) |
Strategic deals listed for context, not included in the $80B-$100B aggregate:
| Deal | Acquirer | Status | Date | EV | Source | Confidence |
|---|---|---|---|---|---|---|
| Albertsons / Kroger | Kroger (strategic) | REGBLOCK | December 10 2024 | $24.6B | NPR | HIGH |
| Spirit / JetBlue | JetBlue (strategic) | REGBLOCK | January 16 2024 | $3.8B | CNBC | HIGH |
| Hawaiian / Alaska | Alaska (strategic) | Closed | September 18 2024 | $1.9B | Legal Dive | HIGH |
Twitter v. Musk is the single most consequential M&A litigation of the 2020-2026 era because it confirmed in practice that a Delaware court will and can order specific performance to close a multibillion-dollar transaction. Sponsors and strategic buyers now price the McCormick risk into walk-away decisions across the board.
The sequence per Fordham Journal of Corporate & Financial Law [HIGH] and Goodwin Procter’s July 2022 securities snapshot [HIGH]:
The Delaware precedent that mattered was McCormick’s 2021 KCake Acquisition decision granting specific performance to a private-target seller against a sponsor. By the time Twitter v. Musk arrived in July 2022, sophisticated practitioners knew McCormick would not flinch. The forced-close template was now operative.
The downstream consequence is that the Wall Street bank syndicate (Morgan Stanley, Bank of America, Barclays, MUFG, BNP Paribas, Mizuho, Societe Generale) was left holding approximately $13 billion of debt at the October 28 2022 close. Much of that debt was marked at 60 to 70 cents on the dollar through 2023 and into 2024 [HIGH; sources include Bloomberg banking-desk reporting and quarterly bank 10-Q disclosures]. Fidelity Blue Chip Growth marked its Twitter (X) equity position down 71.5 percent in its October 2023 NAV to $19.66 billion implied valuation [HIGH; Fidelity quarterly disclosure].
The TEGNA termination is the marquee example of an indirect regulatory block: no formal denial, just procedural delay sufficient to exhaust the financing window. The mechanics matter for sponsors evaluating broadcast, telecommunications, defense, and rail acquisitions where the FCC, the Surface Transportation Board, the Committee on Foreign Investment in the United States, or a state utility commission can drag review past financing commitment expiration.
Standard General LP (founded by Soohyung Kim) and Cox Media Group (Apollo majority owner) agreed to acquire TEGNA at $24.00 per share on February 22 2022. The $5.4 billion equity, $8.6 billion enterprise value transaction would have made Standard General one of the largest minority-owned broadcasters in the United States. The deal required FCC approval because of TEGNA’s owned and operated television-station portfolio.
The sequence per the FCC Hearing Designation Order [HIGH] and the Media Institute [HIGH]:
TEGNA shares closed at $24.00 the day before announcement; the day after termination on May 23 2023 they traded at $19.78, a roughly 18 percent decline. The market priced in the regulatory-block risk well before financing expiration, but the share-based break fee meant TEGNA effectively received a buyback at a known cost basis.
Practitioner takeaway: in transactions requiring license-transfer review by the FCC, the Surface Transportation Board, or a state PSC or utility commission, a Hearing Designation Order has historically functioned as a de facto block because ALJ proceedings can extend 12 to 24 months. Sponsors negotiating these deals in 2026 are now uniformly insisting on regulatory-outside-date provisions of 24 months or longer and on financing commitments with at least matching duration.
United Rentals and H&E Equipment Services signed at $92.00 per share, $3.4 billion equity, on January 14 2025. Herc Holdings went hostile during the 35-day go-shop with a $104.89 per share cash-and-stock bid. URI walked away on February 18 2025 per its press release [HIGH], and Herc agreed to pay URI’s $63.52 million termination fee per Bloomberg [HIGH] and the Rental Equipment Register [HIGH]. The Herc/H&E transaction closed June 2 2025.
Why the case matters: in a competitive overbid environment, the original buyer’s break fee can effectively be cost-shifted to the overbidder. URI structured its January 14 2025 merger agreement with a go-shop provision and a break fee, and the overbidder Herc accepted the fee as a cost of the over-the-top transaction. This is the template for any sponsor running an auction-via-go-shop on a publicly traded target where competing bids are foreseeable. The cost of optionality is shifted to the winning bidder.
Thoma Bravo agreed to acquire Anaplan at $66.00 per share, $10.7 billion equity, on March 20 2022. By May 2022, Thoma Bravo asserted that Anaplan had breached an interim operating covenant by issuing approximately $32 million in equity grants to officers and directors. The parties renegotiated; the new price was $63.75 per share, $10.4 billion, a $300 million-plus aggregate reduction per the Cadwalader release [HIGH]. The deal closed at the re-cut price on June 21 2022 per PE Hub [HIGH].
Axios’s June 2022 analysis [HIGH] called this “Thoma Bravo’s big tech repricing” and predicted (correctly) that sponsors would use any post-signing event of marginal materiality to argue for price reductions through the 2022 hung-debt window. The Anaplan precedent meaningfully shifted negotiating power in the late 2022 and 2023 take-private vintage: sellers became more careful about ordinary-course covenants and the corresponding rights to indemnification.
Permira agreed to acquire Squarespace at $44.00 per share, $6.6 billion equity, $6.9 billion enterprise value, on May 13 2024. Institutional Shareholder Services recommended a vote against the transaction in September 2024 on price grounds. The original tender failed at the majority-of-minority condition. Permira raised the price to $46.50 per share on September 9 2024 per US News [HIGH] and the merger agreement was amended per PRNewswire [HIGH]. The deal closed at the increased price on October 14 2024.
The Squarespace re-cut-up is the rarer direction. RECUT-DOWN is more common because sponsors use the period between signing and closing to argue for relief; RECUT-UP requires the target to wield public-shareholder voting power against a sponsor whose financing is committed and whose reputation depends on closing. The Squarespace case suggests that ISS recommendations carry materially more weight than the pre-2023 PE-sponsor playbook had assumed. Sponsors negotiating tender-offer structures in 2026 should price the ISS-veto risk into their initial premium.
KKR took Envision Healthcare private in 2018 at approximately $5.5 billion of equity and roughly $10 billion enterprise value. Envision was the largest physician-services platform in the United States. KKR’s thesis was that scale economics and revenue-cycle technology would drive margin expansion across the emergency-medicine, anesthesia, and radiology specialties.
Three intervening developments destroyed the thesis per the White Coat Investor analysis [MEDIUM, secondary source on KKR thesis but useful for synthesis] and the Fierce Healthcare [HIGH] filing coverage:
Envision filed Chapter 11 on May 14 2023. KKR’s equity stake of approximately $3.5 billion (per multiple secondary-source reports) was written off. The lenders converted and emerged in roughly November 2023 with debt down 70 percent per Healthcare Dive [HIGH].
For the academic-finance audience: the Envision case is the cleanest empirical test of the “PE healthcare-roll-up thesis” failure mode. The original thesis assumed payer-friendly regulatory persistence; the actual outcome was payer-favorable federal legislation that ended the rents the platform had monetized. The lesson for 2026 healthcare-PE underwriting is that statutory and regulatory rent-extraction has structurally weakened, and underwriting that assumes its persistence is asymmetrically exposed.
Steward Health Care is the most legally and politically consequential PE-healthcare failure of the cycle. Cerberus acquired the platform in 2010 out of the Caritas Christi system; sold the platform to a physician partnership (led by founder-CEO Ralph de la Torre) in 2020; the platform filed Chapter 11 on May 6 2024 with approximately $9 billion of debt. Operations spanned 31 hospitals across 8 states.
The legal posture is what distinguishes Steward from other CH11 cases:
Cerberus’s public response [HIGH on the source as Cerberus statement; HIGH on Cerberus’s framing of having exited four years before bankruptcy] disputes the value-extraction characterization. The litigation is active.
The Steward case is the citation hook for the Eileen Appelbaum / Center for Economic and Policy Research healthcare-PE literature, the PESP healthcare-bankruptcy data, and the AMA Journal of Ethics May 2025 piece on PE-healthcare legal tools [HIGH]. It is also a Delaware Chancery test case for the doctrine of corporate-veil-piercing on a PE-era director-and-officer basis. Practitioners should watch the litigation through 2026 and 2027 for the first Delaware (or relevant state) ruling on directors’ duties in the run-up to a sponsor-initiated CHOW (change of ownership).
Vista Equity Partners and Evergreen Coast Capital (Paul Singer’s Elliott vehicle) agreed to take Citrix Systems private at $16.5 billion enterprise value in January 2022. The deal closed September 30 2022. The bank syndicate (Bank of America, Credit Suisse, Goldman Sachs, Mizuho, Royal Bank of Canada, Citigroup) committed approximately $15 billion of debt financing. At close, they could not sell approximately $6.5 billion of that debt into the broadly syndicated loan market per Bloomberg’s September 20 2022 reporting [HIGH] and Bloomberg’s September 22 2022 follow-up [HIGH].
The portion that did clear cleared at a mark-to-market loss of approximately $600 million to $700 million. The remainder sat on the banks’ balance sheets through 2023, into 2024, with periodic distributions to investors at varying discounts. The American Prospect’s “Griftrix” investigation [HIGH on first-pass sourcing] argues that the structure benefited Vista and Elliott at the expense of bank-shareholder economic value and bank-employee bonus pools.
The post-close operating entity, Cloud Software Group (formed by merging Citrix with TIBCO, which Vista already owned), carries the consequence at the operating-company level: interest expense significantly above the original underwriting assumption, refinancing risk through 2025 and 2026, and customer-base pressure from competitors (notably Microsoft) that did not face the same capital-structure overhang.
The Citrix hung-debt event is the structural anchor for any discussion of the 2022-2023 take-private slowdown. It cracked the megadeal LBO cadence, repriced sponsor-bank LBO commitment terms (with tighter market-MAC carve-outs and flex pricing), and conditioned the recovery in 2024.
Alimentation Couche-Tard (Quebec-based convenience-store strategic, not a PE sponsor; included here for completeness because of the implied $47 billion deal size and the public visibility of the failure) approached Seven & i Holdings on August 19 2024 with an indication of $14.86 per share. Seven & i’s board declined to engage on terms. Couche-Tard raised in March 2025 to $18.19 per share, approximately $47 billion implied enterprise value, a roughly 30 percent premium.
Couche-Tard withdrew on July 17 2025 per C-Store Dive [HIGH], CNN [HIGH], and the consolidated C-Store Dive timeline [HIGH]. Couche-Tard cited “lack of constructive engagement.” Seven & i pursued internal restructuring instead. Seven & i shares fell approximately 20 percent in the week after withdrawal.
The case demonstrates the inverse of the Twitter forced-close: where a board refuses to engage and there is no signed merger agreement, the buyer can walk regardless of premium. Sponsors negotiating cross-border take-privates of Japanese, German, and French targets should expect target-board structural resistance and price the optionality accordingly.
Arkhouse Management and Brigade Capital opened with a December 2023 indication at $21 per share for Macy’s. Macy’s lead independent director Paul Varga rejected on financing-certainty grounds. Arkhouse then waged a proxy fight; Macy’s settled by adding two Arkhouse-nominated directors to the board in April 2024 per CNBC [HIGH]. Arkhouse and Brigade then raised to $24.80 per share, $6.9 billion implied equity.
Macy’s board ended talks on July 15 2024 per CNBC [HIGH] and Retail Dive [HIGH] over the same financing-certainty concern Varga had identified seven months earlier. Macy’s shares traded around $18 at termination, down approximately 27 percent versus the $24.80 proposal. Shares re-rated lower through 2024 as macro and tariff overhang built.
The Macy’s case is the template for activist-led take-private attempts where the financial-sponsor partner cannot demonstrate fully committed financing. Boards have become disciplined about distinguishing “letter of intent” from “binding commitment papers” and will use the absence of the latter as ground for refusal even after months of engagement.
Ares Management and Canada Pension Plan Investment Board took 99 Cents Only Stores private in 2012 at $1.6 billion. The platform filed Chapter 11 April 7 2024 with $456.9 million in debt per Petition11 [HIGH]. Full liquidation followed, including 371 store closures and over 10,800 jobs lost per the Robin Report [HIGH].
Per the PESP May 2025 report [HIGH] on 2024 billion-dollar bankruptcies, 99 Cents Only was one of approximately 18 PE-backed billion-dollar bankruptcies that calendar year. The Ares and CPPIB combined equity stake was wiped. The CPPIB participation matters for the academic-finance audience because public pension funds increasingly hold direct PE platform equity through co-investment arrangements; the 99 Cents Only outcome is a transparent case of pension-LP loss on a co-investment platform that did not reach exit.
Artal Group acquired WeightWatchers from Heinz in 1999 at $735 million and remained the controlling shareholder through the May 6 2025 Chapter 11 filing per the WW International 8-K [HIGH]. The platform emerged in approximately mid-June 2025 with creditor-controlled equity.
The proximate cause was GLP-1 receptor agonist disruption: semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) achieved 15 to 20 percent weight-loss outcomes in clinical trials that the points-counting behavioral-modification WW protocol could not match. The Oprah-Winfrey-led brand revival of 2015 (via her purchase of approximately 10 percent of WW shares and her board seat) was insufficient against the pharmacological substitution risk.
The case is significant for two reasons. First, it is the canonical example of a multi-decade PE hold ending in equity impairment because of an exogenous technological substitution. Second, it tests the academic-finance framing of “PE creates value” against the counterfactual of a publicly traded WW absent Artal sponsorship: the substitution risk was symmetric, but the debt structure that Artal preserved across multiple recapitalizations did not survive the cash-flow shock.
Red Lobster (taken private by Golden Gate Capital from Darden Restaurants in 2014; partially sold to Thai Union Group later) filed Chapter 11 in May 2024. The triggering event reported by trade press was the “Ultimate Endless Shrimp” promotion losses, but the structural cause was a 2014 sale-leaseback under Golden Gate that left Red Lobster with above-market rents on a substantial portion of its restaurant base. [HIGH on the bankruptcy filing date; MEDIUM on the precise PE attribution of the sale-leaseback structure pending primary-source confirmation in liquidating-trustee filings].
The Red Lobster case is included in the failure dataset because it illustrates the PE-induced sale-leaseback failure mode: the sponsor monetizes real estate at close, the operating company assumes lease liability, and a subsequent revenue contraction or unit-economic shock produces insolvency that a non-PE owner with owned real estate would have survived. The pattern recurs in the Steward case (the 2016 Medical Properties Trust sale-leaseback funded the $790 million Cerberus dividend), in the Joann fabric-stores case (PE sponsor Leonard Green’s prior involvement and the 2018 sale-leaseback), and in the 99 Cents Only case (Schottenstein and Ares-era real-estate monetization).
Joann Stores filed Chapter 11 in March 2024, emerged in April 2024, then filed again in January 2025 and ultimately liquidated in February 2025. Leonard Green & Partners was the controlling PE sponsor for the 2011-2024 hold period. The platform’s failure to revive post-emergence is the cleanest 2025 case of a “Chapter 22” (sequential Chapter 11) in PE-owned retail.
[HIGH on the bankruptcy filing dates; MEDIUM on Leonard Green’s specific equity-recovery position in the post-emergence cap table pending primary-source confirmation from the second-filing docket.]
The case matters for the dataset because it confirms a structural fragility in PE-revived retail: emergence with debt reduced but with no fundamental change in operating economics or e-commerce competitive position frequently does not survive a second cyclical downturn. Sponsors and lenders structuring 2026-vintage retail restructurings should be skeptical of “emerge-and-grow” base cases when category economics have shifted to digital-first competitors.
LL Flooring (formerly Lumber Liquidators) filed Chapter 11 on August 11 2024 with $456.9 million in debt. Multiple PE bidders engaged during the pre-bankruptcy strategic review but no transaction closed. F9 Investments, the personal investment vehicle of founder Tom Sullivan, acquired 219 stores and the brand IP for up to $43 million per Retail Dive [HIGH] and Richmond BizSense [HIGH]. The remaining 211 stores closed. The platform was rebranded back to Lumber Liquidators.
The case illustrates that founder-led rescue is materially more efficient than PE-led restructuring when the brand equity is intact but the operating platform is overlevered. The F9 transaction price represented approximately 9 cents on the dollar of pre-petition debt.
Renovo Home Partners was created in 2021 by Audax Private Equity as a roll-up of seven independent home-services operators: Dreamstyle, Alure, Remodel USA, NEWPRO, Woodbridge, Reborn, and Minnesota Rusco. Audax exited the platform in 2024 (transaction terms not publicly disclosed); BlackRock TCP Capital Corp held the senior debt and became the de facto equity sponsor. Renovo filed Chapter 7 (not Chapter 11) on October 30 2025 per USA Herald [HIGH] and the Qualified Remodeler [HIGH] coverage.
The Star Tribune’s anatomy of the Minnesota Rusco collapse [HIGH] is the most detailed PE-roll-up case study in the lower-middle-market home-services category for 2025. The piece documents customer deposits stranded mid-job, employees without WARN Act notice, and operator complaints about the integration process having stripped local managerial autonomy and vendor relationships in the years preceding collapse.
The Renovo case is the citation hook for any 2026 conversation about PE lower-middle-market roll-up risk in home services, HVAC, plumbing, electrical, landscaping, and pest control. Sponsors underwriting these acquisitions should incorporate the “integration failure mode” explicitly in base-case modeling, and lenders should price WARN Act and customer-deposit-recovery risk into senior-debt terms.
The PE Healthcare bankruptcy cluster of 2023-2025 is the most concentrated single-vertical PE failure event of the cycle. The PESP April 2024 report quantifies the trend [HIGH]: 17 PE-backed healthcare Chapter 11 filings in 2023 versus 8 in 2019, a 112 percent increase. PE-backed filings represented 21 percent of all healthcare Chapter 11s in 2023.
| Platform | Sponsor | Chapter 11 Date | Debt at Filing | Trigger |
|---|---|---|---|---|
| Envision Healthcare | KKR | May 14 2023 | $7B+ | No Surprises Act + UHC dispute + labor inflation |
| Air Methods | American Securities | October 24 2023 | $2.24B | No Surprises Act + labor inflation |
| Steward Health Care | Cerberus (legacy) / physician partnership | May 6 2024 | ~$9B | Sale-leaseback rent burden + dividend recap history |
| Cano Health | InTandem + Crestview (pre-IPO) | February 4 2024 | $1.2B+ | Pre-IPO debt + $100M dividend recap |
| American Physician Partners | Brown Brothers Harriman Capital | September 18 2023 | up to $1B | No Surprises Act $3.2M/month impact |
| SmileDirectClub | CDR (pre-IPO) | September 29 2023; converted to Ch 7 January 26 2024 | ~$900M | Direct-to-consumer dental disruption + FDA scrutiny |
The CEPR Genesis Healthcare write-up at https://cepr.net/publications/inside-the-genesis-private-equity-bankruptcy-case/ [HIGH] documents the Eileen Appelbaum framing for the broader academic-finance audience. The PESP “Private Equity’s Failed Bet on Value-Based Care” May 2025 report [HIGH] expands the dataset to include value-based-care PE failures specifically.
The structural drivers of the cluster:
For 2026 healthcare-PE underwriting, the lesson is that statutory rent-extraction has structurally weakened. Sponsors that priced 2018-2021 vintage healthcare platforms on assumed rent-persistence have written down billions. Sponsors underwriting 2026 vintage should assume rent-erosion and price the asymmetry into entry multiples.
Two single transactions account for the bulk of the hung-debt overhang from the 2022 cycle: Vista/Citrix at approximately $6.5 billion and Musk/Twitter at approximately $13 billion. Combined, the syndicate banks (Bank of America, Morgan Stanley, Barclays, MUFG, BNP Paribas, Mizuho, Societe Generale, Credit Suisse, Goldman Sachs, Royal Bank of Canada, Citigroup) held approximately $19 billion of LBO-related debt that could not clear into the broadly syndicated loan market at close.
The implications cascaded:
Twitter v. Musk (C.A. No. 2022-0613) is the single most consequential M&A litigation of the 2020-2026 era. Chancellor McCormick had granted specific performance in 2021’s KCake Acquisition decision and would have done so for Twitter on October 17 2022; Musk’s October 4 capitulation removed the necessity of a judgment. Sponsors and strategic buyers now structurally price the McCormick-risk into walk-away decisions. Deal lawyers have responded by expanding negotiation around specific performance carve-outs, but the post-2022 baseline assumption is that Chancery will order close.
| Deal | Fee paid | By whom | Date | Source | Confidence |
|---|---|---|---|---|---|
| TEGNA / Standard General | $136M (in 8.64M TEGNA shares) | Standard General | May 22 2023 | TEGNA 8-K | HIGH |
| H&E / United Rentals | $63.52M (paid by Herc) | Herc | February 2025 | URI release | HIGH |
| Spirit / JetBlue | $69M | JetBlue | March 4 2024 | CNBC | HIGH |
| Twitter / Musk | $0 (forced close) | n/a | n/a | Twitter 8-K | HIGH |
| Macy’s / Arkhouse + Brigade | $0 (no definitive agreement) | n/a | n/a | CNBC | HIGH |
| 7-Eleven / Couche-Tard | $0 (no definitive agreement) | n/a | n/a | C-Store Dive | HIGH |
GAP: a comprehensive break-fee table for the full 2020-2026 PE take-private universe is not publicly aggregated. CT Acquisitions could compile this from DEF14A and 8-K filings as a future research project.
The Reid Collins & Tsai November 24 2025 amended complaint in the Steward liquidating-trustee litigation seeks $3.4 billion against de la Torre and former PE-era directors. The complaint’s “systematic value extraction” framing maps onto a corporate-veil-piercing theory specific to the run-up to a PE-sponsor-initiated CHOW. If Delaware (or the relevant state court) accepts the framing in any of the next 18 months, it will function as a litigation deterrent on dividend-recap-then-exit transactions in healthcare PE structurally similar to the post-2008 fraudulent-conveyance jurisprudence in private-equity-led real-estate transactions.
The buyout machine is running hot again. 2025 global buyout value: $904 billion, up 44 percent per Bain. Fundraising has not recovered to pre-2021 highs and over a third of 2024 fund closes took 24+ months. The pipeline of failures is unlikely to slow even as deal value resumes growth, because:
The failure data has direct implications for LP fund-marks and IRR reporting that the institutional-finance press has under-discussed. Three mechanisms:
The Institutional Limited Partners Association has the right institutional position to demand a structured, time-series-aware failure-rate denominator. CT Acquisitions invites ILPA to incorporate the dataset published in this report into LP-side fund-due-diligence checklists.
Related research: for 16-carrier R&W comparison with AM Best + Moody’s + S&P + Fitch ratings; Marsh $91.6B placed 2025 (+34% YoY); 53/47 corporate/PE split; -14% NA RoL 2024 reversed to +16% NA 2025; Aon $3B+ cumulative recoveries; median claim $8.2M 2025 vs $5.5M 2024; Aon/NFP $13B April 25 2024; CRC/Euclid Jan 2026, see the 2024-2026 R&W Insurance Carrier Comparison.
Related research: for $183B global STR market with the distressed-PE consolidation cycle (Vacasa-Casago $128.6M April 30 2025 Steve Schwab CEO; Sonder Chapter 7 Nov 14 2025 post Marriott license termination; NYC LL18 22,246 to ~4,000 listings; Maui Bill 9 Dec 15 2025; Hignell-Stark 5th Cir Oct 7 2025; EU 2024/1028 full compliance May 20 2026), see the 2024-2026 Short-Term + Vacation Rental Management Distressed PE Tracker.
Related research: for Total secondary $233B 2025 / GP-led $115-116B / CV-specific $106B Evercore (51% YoY), Vista Cloud Software $5.6B June 2025 at disclosed 5% discount to Q1 2024 NAV (most specific public disclosure), 90%+ GP-led H1 2025 less than 10% discount, LP-portfolio 87% NAV, 5th Cir PFAR vacatur June 5 2024, see the 2024-2026 PE Continuation Vehicle Discount-to-NAV Tracker.
Related research: for 17 named US PE sponsors with 3+ platforms in same vertical (Welsh Carson 8 healthcare platforms with USAP 19.99% cap May 12 2025 = first sponsor-level prior-approval remedy; Linden 7; KKR 6; Carlyle 4-MGA NSM+Hilb+Trucordia+Vantage), 10 vertical heat maps, and the state AG patchwork (CA SB 351 + OR SB 951 + WA HB 2548) as the new pre-merger notification regime, see the 2024-2026 PE Sponsor-by-Vertical Concentration Heat Map.
Related research: for Cerulli updated $124T Great Wealth Transfer through 2048, UBS 91 heirs / $297.8B 2025, OBBBA July 4 2025 $15M estate exemption permanent, Murdoch Sept 8 2025 $3.3B settlement = Succession TV template, Tata Noel Oct 11 2024, Samsung 12T won May 2026 inheritance tax completion, Chey Tae-won Oct 16 2025 Supreme Court reversal, see the 2024-2026 Family Office Succession + Generational Wealth Transfer Tracker.
Related research: for 200+ named US + EU + Asia SFOs with 60+ named direct PE deals 2024-2026 (Mars-Kellanova $35.9B Aug 2024, Ellison-Paramount $8B close Aug 7 2025, Hinduja-Reliance Capital INR 9,650cr March 18 2025, Pinault-CAA $7B 2023-24, PPC IV $3.4B Aug 2025 final close, Reuben-W South Beach $425M Oct 2024, Crown-Rockefeller Center $3.5B Nov 2024) plus the JAB BBB downgrade + INEOS + Artémis stress counter-narrative, see the 2024-2026 Top 200 Single Family Office Direct PE Investment Tracker.
Related research: for every US state AG filing + notification law on healthcare PE 2024-2026 (CA SB 351 effective Jan 1 2026 NOT vetoed AB 3129; OR SB 951 NOT failed HB 4130; IN SEA 9; WA HB 2548 = first US sale-leaseback pre-notify statute; MA H 5159; Walgreens/Sycamore Aug 2025), see the 2024-2026 State AG and Legislature Healthcare PE Enforcement Tracker.
Related research: for DHJLM NBER 26371 applied to named PE bankruptcies 2024-2026 (65,850 documented 2024 layoffs per PESP; Steward 30K, Red Lobster 36K, Yellow Corp 30K, Joann 19K, Prospect Medical 11.3K, Envision 25K), see the 2024-2026 PE Roll-Up Job Cohort Study (QCEW Replication of DHJLM).
We catalogued 31 named cases spanning withdrawn, re-cut, forced-closed, financing-collapsed, and in-hold-period Chapter 11 outcomes. The full table appears in Section 6. Confidence: HIGH on case-by-case basis; MEDIUM on aggregate enumeration completeness.
$80 billion to $100 billion, excluding strategic deals like Albertsons/Kroger ($24.6B) and Spirit/JetBlue ($3.8B). Confidence: MEDIUM (estimate range, sensitive to inclusion criteria).
KKR’s 2018 Envision Healthcare take-private ($10 billion enterprise value), where equity was wiped in the May 14 2023 Chapter 11 filing. Approximately $3.5 billion of KKR fund equity written off per multiple secondary-source reports. Confidence: HIGH on the bankruptcy; MEDIUM on the precise dollar writeoff.
The $3.4 billion amended complaint by the Steward Health Care liquidating trustee (Reid Collins & Tsai) filed November 24 2025 against former CEO Ralph de la Torre and former PE-era directors. Confidence: HIGH.
Delaware Chancellor Kathaleen McCormick had granted specific performance in the 2021 KCake Acquisition decision and set an October 17 2022 trial for Twitter v. Musk on July 19 2022. Musk capitulated October 4 2022 to avoid an almost certain order to close. Twitter closed at the original $54.20 per share on October 28 2022. Confidence: HIGH.
The FCC Media Bureau’s Hearing Designation Order of February 24 2023 sent the transaction to an Administrative Law Judge. ALJ proceedings can last 12 to 24 months. Standard General’s financing commitment window expired before the proceedings could conclude. TEGNA collected the $136 million termination fee in 8,640,452 transferred TEGNA shares on May 22 2023. Confidence: HIGH.
URI’s January 14 2025 merger agreement with H&E Equipment Services included a 35-day go-shop provision. Herc went hostile at $104.89 per share cash-and-stock during the go-shop, significantly above URI’s $92.00 per share. URI walked February 18 2025; Herc agreed to pay URI’s $63.52 million termination fee as a cost of the over-the-top transaction; the Herc/H&E deal closed June 2 2025. Confidence: HIGH.
17 of 80 (21 percent) per the PESP April 2024 report, a 112 percent increase from 8 PE-backed filings in 2019. Confidence: HIGH on the PESP data.
The Bank of America, Credit Suisse, Goldman Sachs, Mizuho, Royal Bank of Canada, and Citigroup syndicate held approximately $6.5 billion of unsold Citrix debt at the September 30 2022 close per Bloomberg. The portion that did clear cleared at a mark-to-market loss of approximately $600 million to $700 million. Confidence: HIGH.
Chapter 11 inside the hold period, distressed exchanges, and continuation-vehicle / GP-led secondaries can all be used to defer or obscure recognition of impairment in fund marks. LPs evaluating sponsor track records should incorporate the failure dataset and ask sponsor-by-sponsor questions about prior hold-period writedowns and timing.
CT Acquisitions is a private-equity intelligence and platform-tracking research firm. We publish denominator-aware deal-flow analytics, vertical-specific PE platform maps, sponsor-by-sponsor activity trackers, and counter-narrative pieces designed for institutional investors, deal-team practitioners, financial journalists, and academic researchers. Our PE take-private failure tracker is updated continuously. Researchers and practitioners interested in collaboration on the denominator-construction problem (Section 4) can reach the editorial team via the contact page at ctacquisitions.com.
Last updated: June 21, 2026.